Mutagenicity of hydroxamic acids and the probable involvement of carbamoylation. 1980

P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop

A series of hydroxamic acids (aceto-, propiono-, benzo-, and p-nitrobenzo-) and seven derivatives of these were examined for biological activity using Salmonella typhimurium. Acylation to yield O-acetyl and O-benzoyl derivatives markedly enhanced toxic properties and was necessary for mutagenic activity for all but p-nitrobenzohydroxamic acid. The dose necessary to produce a minimum significant mutagenic response varied from 21 microM for O-benzoyl benzohydroxamate to 430 microM for O-acetyl acetohydroxamate. These two compounds were also tested with human lymphoblasts to which they were toxic at 100 microM but not mutagenic. O-Acetyl benzohydroxamate, a mutagen, was prepared wih a 14C label in the carbonyl carbon atom of the benzoyl group and was shown to form an adduct in vitro with DNA and polyguanylic acid. The level of binding was 1 mol of 14C per 5 X 10(4) mol of DNA phosphate and 1 mol of 14C per 10(5) mol of polyguanylic acid phosphate.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011068 Poly G A group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Guanine Polynucleotides,Polyguanylic Acids,Acids, Polyguanylic,Polynucleotides, Guanine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
January 1985, Toxicology letters,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
April 1977, Antimicrobial agents and chemotherapy,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
September 1977, Mutation research,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
May 1985, Carcinogenesis,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
February 1953, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
February 2001, Kidney international. Supplement,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
January 1985, Mutation research,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
August 2013, Clinical and experimental nephrology,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
May 1946, The Journal of organic chemistry,
P L Skipper, and S R Tannenbaum, and W G Thilly, and E E Furth, and W W Bishop
April 2003, Organic & biomolecular chemistry,
Copied contents to your clipboard!